Human trials of a new medication to treat Parkinson's disease are expected to begin within 3 years
Cross-disciplinary research at the University of Melbourne and the Florey Institute of Neuroscience and Mental Health has found that a class of synthetic compounds called copper bis(thiosemicarbazones) can potentially treat Parkinson's.
Pre-clinical research on the drug strongly indicates that this new medication has the potential to treat Parkinson’s and other neurodegenerative diseases.
Read more:
http://newsroom.melbourne.edu/news/university-melbourne-enters-agreement-develop-therapy-parkinsons-disease
Image via Wikimedia Commons
Oops
ReplyDeleteRemarkable article, it is particularly useful! I quietly began in this, and I'm becoming more acquainted with it better! Delights, keep doing more and extra impressive! depression with anxiety
ReplyDelete